HEAL Partners is a growth private equity fund that focuses on early to mid-stage investments in the health, education, and related lifestyle sectors, emphasizing a partnership model that allows professionals to deliver optimal customer outcomes.

HEAL Partners

HEAL Partners | 882 followers on LinkedIn. Healthcare and Education (and related Lifestyle) | A Growth Private Equity Fund | HEAL is a growth stage private equity fund manager focused on revenue generating growth businesses in the health, education and related lifestyle sectors with the potential for global scale or industry disruption. 

Led by a team of proven founders, investors, portfolio managers and operators, we are focused on capitalising on opportunities created by new specialties in developed markets. 

At HEAL, we are committed to promoting environmental, social and governance (ESG) principles through our investment activities to promote long term sustainability and encourage socially responsible business practices.

CEO AMILI- "Good health starts with gut health"

Jeremy Lim

Director Arc31, Chair AUCloud, Director Brisbane Lions, Director PSA Foundation

Cathie Reid AM

Executive Partner at Factory Capital

Jonathan Keaney

Investment Partner, Chairman and NED in various Technology, Digital, Media, Health and Education business and funds. B.Bus, MBA, GAICD

Martin Dalgleish

We are excited to announce HEAL Fund II's latest investment - a US$ 15m commitment to Crimson Education . Crimson is the world's leading college admissions consulting platform, helping students from around the world gain access to leading colleges and universities. Crimson also operates Crimson Global Academy , a global, leading online private school, connecting world-class teachers to ambitious students. HEAL first invested in Crimson, through Fund I, three years ago, and have been thrilled with the company's progress and development since. We look forward to building on our relationship with Jamie Beaton and the Crimson team. HEAL Partner, Martin Dalgleish , has joined the board of Crimson as part of this investment. This investment is the third completed deal for Fund II, following investments in Removery , the world's leading tattoo removal platform headquartered in Austin, Texas, and in The Fertility Partners , Canada's leading fertility platform. We are also in the final stages of diligence for Fund II's fourth investment - further details will be announced in the next few weeks! Fund II recently secured Second Close at ~A$ 200m, i.e. approximately the same size as Fund I, with strong indication of further commitments into Final Close targeted in mid-2025.

We're proud to continue our collaboration with fund managers to provide a wide range of investment options for advisers and their clients. In September we onboarded several new managed funds onto our platform, offering investors new opportunities to diversify and grow their portfolios. This unlocks new growth avenues for wealth practices. See the list below: * Arnott Opportunities Carbon Fund * Blackwattle Long-Short 130/30 Quality Fund * Hybrid Income Fund * FNC Follow-on Fund * HEAL Partners Australia Fund 2 Pty Ltd * iCapital Private Markets Fund (Hedged) - AUT * iCapital Private Markets Fund (Unhedged) - AUT * Yarra Higher Income Fund * Lazard Select Australian Equity Fund - S Class * Pallas Senior Income Fund * Potentum Global Access Fund * RF CorVal Tottenham Trust * Regal Australian Long Short Equity Fund * Scarcity GP Access Fund Class C * Vanguard Active Positive Impact Fund * iShares MSCI Emerging Markets ex China ETF Arnott Capital Blackwattle Investment Partners Seed Partnerships Future Now Capital HEAL Partners iCapital Yarra Capital Management Lazard Asset Management Pallas Capital Potentum Partners RF Corval Regal Funds Management Scarcity Partners Vanguard Australia iShares

Mason Stevens

We are pleased to announce that Fund II has secured Second Close at ~A$ 200m, i.e. approximately the same size as Fund I, with strong indication of further commitments into Final Close targeted in mid-2025. Fund II has completed two investments to date, in Removery , the world's leading tattoo removal platform headquartered in Austin, Texas, and in The Fertility Partners , Canada's leading fertility platform. Investments #3 and #4 have been secured with completion subject to confirmatory diligence and approvals. Further details to follow over the next few weeks! We would like to thank our incoming and existing investors for their strong support and look forward to a successful partnership! We would also like to welcome Sam Goldwater to Fund II's LPAC. Sam is the Co-Founder and CIO of Generate Investment Management, a New Zealand KiwiSaver and wealth fund manager with approximately A$ 6bn in AUM. We are excited to partner with Generate KiwiSaver Scheme on Fund II! Martin Robinson

We are excited for this partnership between HEAL portfolio company, Us2.ai and Advara HeartCare , the largest provider of cardiac healthcare services in Australia, aimed at enhancing heart disease detection, diagnosis and treatment. Us2.ai is a leading provider of AI-automated echocardiography solutions and is on a mission to automate the fight against heart disease. The company’s advanced AI algorithms assist healthcare professionals in diagnosing and treating heart disease more accurately and efficiently, and integrate seamlessly into clinical workflows, providing valuable insights that improve patient care and outcomes.

COM:HEALPARTNERS

HEAL Partners

Analysis Not Available